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Identification of the phase 
composition of solid microparticles 
in the nasal mucosa of patients 
with chronic hypertrophic rhinitis 
using Raman microspectroscopy
Kristina Čabanová1,2*, Oldřich Motyka3, Hana Bielniková4, Lenka Čábalová5, Petr Handlos6, 
Dominika Zabiegaj7, Karol Zeleník5, Jana Dvořáčková4, Pavel Komínek5, Silvie Heviánková2, 
Miroslav Havlíček8 & Jana Kukutschová1
Solid particles, predominantly in micron and submicron sizes, have repeatedly been observed as 
a threat to a human health unique compared to the other textures of the same materials. In this 
work, the hypothesis the solid metal-based particles play a role in the pathogenesis of chronic 
hypertrophic rhinitis was investigated in patients who had not responded positively to medication. 
In the group of 40 randomly selected patients indicated for surgical mucotomy, the presence of solid 
micro- and submicron particles present in their nasal mucosa was assessed. For comparison, a set of 
13 reference samples from patients without diagnosed chronic hypertrophic rhinitis was evaluated. 
The analysis was performed using Raman microspectroscopy. The advantage of this method is the 
direct identification of compounds. The main detected compounds in the mucosa samples of patients 
with chronic hypertrophic rhinitis were  TiO2, carbon-based compounds,  CaCO3, Ca(Fe, Mg, Mn)
(CO3)2  MgCO3,  Fe2O3,  BaSO4,  FeCO3 and compounds of Al and Si, all of which may pose a health risk 
to a living organism. In the reference samples, only  TiO2 and amorphous carbon were found. In the 
control group mucosa, a significantly lower presence of most of the assessed compounds was found 
despite the longer time they had to accumulate them due to their higher mean age. Identification 
and characterisation of such chemicals compounds in a living organism could contribute to the overall 
picture of the health of the individual and lead to a better understanding of the possible causes not 
only in the chronic hypertrophic rhinitis, but also in other mucosal and idiopathic diseases.
The micron- and submicron particles are continuously observed as a unique toxicological entity. Such materials 
are often characterised by their particle size—similar to the size of cells or subcellular structures, large specific 
surface and the surface disruptions resembling the active sites of enzymes, proteins and antibodies. These proper-
ties give a new way of toxicity even to the materials which are not recognised as harmful in bulk or in solution. 
The continuing revelations of newly observed risks for human and public health connected with the presence 
of micron- and submicron particles in the environment raise legitimate concerns about their management. 
According to the World Health Organisation (WHO), ambient air pollution contributed to 7.6% of all deaths in 
2016 worldwide. The WHO data show that 9 out of 10 people breathe air containing pollutants in high concentra-
tions, leading to 7 million excess deaths worldwide annually. Dispersed in air particles, they pose a serious risk 
to human health—an increasing number of associations have been reported between the air particulates and a 
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range of  diseases1, causing adverse health effects such as increased incidences of strokes, Alzheimer’s disease, 
respiratory and cardiovascular diseases, and  cancer2.
Moreover, with the developments in industries and transport and the progress in pharmacology and medi-
cine, the risk of environmental exposure of humans to these particles  increases3. Hence, it is widely believed that 
humans, living in the close neighbourhood to highways and  roads4, in urban and industrial areas, are exposed 
to such particles on a daily  basis5.
Naturally, the risks related to the harmful nature of the micron- and submicron particles differ significantly 
with the specific exposure route. The contact with these particles through the digestive system (ingestion expo-
sure) and skin (dermal exposure) requires the mere presence of the particles in either the environment or food 
and, therefore, are of particular concern. On the other hand, the healthy human body is protected from such 
exposure by a number of natural factors (compactness and hydrophobicity of skin, stomach acid, gastrointesti-
nal and liver barrier, dermal barrier). Despite that, the adverse effects of the dermal and ingestion contact with 
micron- and submicron particles have been recorded. The most significant risk to the integrity of the human 
body has the direct intravenous exposure to the micron- and submicron particles, yet the possible ways of this 
exposure are limited and, compared to the other possible routes, relatively easily manageable. The contact of the 
micron- and submicron particles with the respiratory system (inhalation exposure), on the other hand, is practi-
cally inevitable in contemporary  environments6. Moreover, the respiratory system does not possess a similar level 
of natural protection characteristic for both dermal and digestive routes of exposure. Thus, the inhalation expo-
sure is of the greatest concern towards the influence of the micron- and submicron particles to public  health7,8.
The fate of the micron- and submicron particles in the respiratory system is mostly affected by their dimen-
sionality. The particles larger than 10 μm are caught on the mucous membrane of the nasal turbinates, then moved 
using the rhythmical movement of the cellular cilia to the oral cavity and usually subsequently swallowed. Smaller 
particles, mainly those with one dimension about 1 μm, keep suspended in the air flowing to the secondary and 
tertiary bronchi and, finally, they diffuse to the pulmonary alveoli wherefrom they are gradually removed by 
phagocytosis or pinocytosis depending on their  size8,9.
The particles under 10 μm have been linked explicitly to various respiratory diseases and conditions, which 
is believed to be caused by their relatively long retention period in the respiratory system. Moreover, multiple 
other respiratory conditions have been suspected of being caused by exposure to ultrafine particles: chronic 
rhinosinusitis (with/without polyposis) is one of them. According to European Position Paper on Rhinosinusitis 
and Nasal Polyps 2020, chronic rhinosinusitis is considered to be a syndrome with a multifactorial aetiology 
resulting from a dysfunctional interaction between various environmental factors and the host immune system. 
In healthy individuals, the mucosa serves as a relative barrier modulating interaction with the host immune sys-
tem, promoting tolerance and symbiosis as well as preventing or limiting inflammation. In patients with chronic 
rhinosinusitis, the barrier is penetrated with resultant chronic inflammation leading to, in many cases, tissue 
remodelling (e.g. mucosal turbinate hypertrophy, polyposis) and clinical  symptoms10. In many patients, the cause 
of chronic inflammation and mucosal hypertrophy is unclear—the rhinosinusitis is idiopathic. As micron- and 
submicron particles can cause mucosa inflammatory changes, it is possible that they can be a cofactor causing 
mucosal hypertrophy.
The treatment of mucosal hypertrophy still remains an open question with many variables, subjected to a 
continuous discussion. As a first-line treatment of hypertrophic inferior turbinate, intranasal steroids are pre-
scribed. In the scenario when the conservative treatment does not produce sufficient effect, surgical treatment 
is  indicated11–13. In the patients with the known cause of chronic rhinosinusitis/inferior turbinate hypertrophy 
(allergy, drug-induced rhinosinusitis), the treatment is mainly causal—such as removing the allergen from the 
environment of the patient, desensitisation, or cessation of daily decongestant use. In many cases, though, the 
exact cause of hypertrophy is unclear. We hypothesise that particularly in patients with chronic rhinosinusitis 
with/without polyposis with unclear aetiology, micron- and submicron particles might play an important role.
The principal aim of the study was to determine the relationships between the compounds found in the 
mucosa tissue of patients indicated for surgical treatment and selected environmental factors that would lead to 
a better understanding of the causes of chronic rhinitis/rhinosinusitis in relation to other idiopathic diseases.
Material and methods
Forty tissue samples of inferior turbinate mucosa were collected from the patients suffering from chronic hyper-
trophic rhinitis that were nonresponsive to intranasal steroid therapy and indicated for endoscopic mucot-
omy. Patients were aged 20–78, both males and females, smokers and non-smokers, manual and office workers 
(Table S1). For comparison, a set of 13 samples was created from cadaveric donors who were not diagnosed with 
chronic rhinitis/rhinosinusitis and whose nasal mucosa was healthy (Table S2).
Sample preparation. The tissue samples, mucosa of the inferior nasal turbinates, were obtained by endo-
scopic “cold-steel” mucotomy under general anaesthesia. The samples were attached to paraffin tablets using 
sterile surgical needles; the orientation of the mucosa was marked on the tablet (anterior and posterior sides). 
Then, the samples were submerged to 10% formalin (Fig. S1). After alcohol-xylene dehydration and automated 
paraffin embedding, 2–4 μm thin sections were cut and mounted onto glass microscope slides. These sections 
were deparaffinised in xylene and alcohol and were not  stained14.
Analytical methods. Raman spectra allowing chemical characterisation of particles/clusters in the samples 
were obtained using Smart Raman Microscopy System XploRA (HORIBA Jobin Yvon, France). Raman spectra 
were acquired in the whole range from 100 to 4000  cm−1. 100× objective lens was used, which is more suitable for 
the samples in thin films or fluids dried on a glass slide. The 532 nm excitation laser source (20–25 mW) with the 
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laser spot diameter of approximately 0.5 µm allowing point analysis of particles/clusters was used. The intensity 
of the laser was regulated with regard to the measured sample—a lower intensity of the laser beam was set due 
to the potential of damage to organic samples. XploRA device allows 0.1, 1, 10, 25, 50, and 100% intensity of the 
initial laser beam. The acquisition time and the number of accumulations were set according to each sample to 
reduce the signal/noise ratio. Grating with 1200 grooves/mm was set. A screen image recorder camera attached 
to the microscope enabled the visualisation of white-light images and the selection of the area of interest. In 
addition, the recording of the spectral images (Raman mapping) was performed in a selected region with 1 µm 
step. Measured Raman spectra were corrected using the LabSpec software of the XploRA™. The baseline cor-
rection (polynomial, order 8th), smoothing (Linear Savitsky-Golay filter, 2nd order, 9 points), and marking the 
position of the Raman bands in the measured individual Raman spectra were performed by LabSpec  software15.
Statistical analyses. The data was analysed using Multiple correspondence analysis (MCA) to assess gen-
eral trends of explained  variation16.
Additional editing of data has been made on the presumptions of limits of the Raman spectroscopy. Namely, 
graphitic and amorphous carbon has been presumed as one indistinctive entity instead of their evaluation as 
two separated items (C). Carbonates as ankerite and calcium carbonate were also included as one separate entity 
(CO). Sulphates  (BaSO4 and  CaSO4) were also considered as one item (SO), as well as ferric oxides  (Fe3O4 and 
 Fe2O3) labelled Fe and  TiO2 anatase and  TiO2 rutile—Ti. The split in detection between anatase and rutile hits can 
be explained by the highly amorphous nature of titania deposited on a human mucosa. In fact, the local crystal-
line structure hit by the laser may resemble either the structure of anatase or rutile and the resulting spectrum 
(either anatase- or rutile-like) is recorded somewhat randomly.
The variables diagnosis (rhinitis × controls), smoking (smoker × non-smoker), age, sex, occupation (manual × 
office) and occupation (inside × outside) taken as supplementary—they were only to describe the model but not in 
its construction. The multivariate assessment was followed by bivariate comparisons of all the pairs of variables—
t-tests for the numeric-categorial combination and chi-square tests for the categorial-categorial combination. All 
the analyses were performed in the R environment, FactoMineR package was used for multivariate  analysis17,18.
Research involving human participants and/or animals. The study was conducted from Septem-
ber 2012 to March 2014 following the approval by the Institutional Ethics Committee of University Hospital 
Ostrava (identifier FNO-ENT-Nanoparticles, 2 RVO-FNOs/2013) and registered at ClincialTrials.gov (identifier 
NCT02270125). The study was performed complying with the Declaration of Helsinki, good clinical practice, 
and applicable regulatory requirements. Informed consent was obtained from all participants prior to the initia-
tion of any procedures.
Ethical standards. Experiments comply with the current laws of the Czech Republic, where they were 
performed.
Results and discussion
Raman microspectroscopy measurements. In the tissue samples (nasal mucosa) of patients with 
chronic hypertrophic rhinitis, the main detected compounds were  TiO2 (anatase, rutile), amorphous carbon 
(AC),  CaCO3 (calcite), Ca(Fe, Mg, Mn)  (CO3)2 (ankerite),  Fe3O4 (magnetite),  MgCO3 (magnesite), graphite 
(Gr),  Fe2O3 (hematite),  BaSO4 (barite),  FeCO3 (siderite). The compounds of Al and Si were also detected, albeit 
less frequently (Table S1). In the reference samples of control group, only  TiO2 (anatase) and amorphous carbon 
were detected (Table S2).
The advantage of Raman microspectrometric analysis is the direct identification of compounds (Fig. 1), 
while it is also possible to get an idea of their size (Fig. S2) thanks to the spectral maps of detected individual 
compounds. The particles found were mostly in micron sizes, but also as clusters of particles smaller than 1 
micron. Submicron-sized particles are highly reactive and tend to  agglomerate19,20, which could explain the fact 
that the observed compounds were determined mainly in the form of agglomerates of much smaller particles.
Statistical analyses. The dataset. Patients in the study group (Table S1) have been selected solely on the 
basis of the indicated mucotomy in University Hospital Ostrava (UHO) and their agreement with providing 
their tissue samples for the study. Therefore, the common factors of the entire group are (a) diagnosis of the 
chronic hypertrophic rhinitis unresponsive to the pharmacotherapy and (b) choosing UHO as their hospital of 
choice (which is usually connected with living in the particular region in the context of the Czech Republic—
UHO usually covers the patients from the Moravian-Silesian region). The other features of the group can be 
viewed as entirely random; therefore, the tendencies observed within the group differing from the properties of 
the general population in the region might be regarded as the potential risk factors of chronic hypertrophic rhi-
nitis. Also, the chi-square Goodness of fit test confirmed that in the group of patients with chronic hypertrophic 
rhinitis, the frequency of males differed significantly—was higher—from their frequency in the general popula-
tion (p = 0.0105). Compared to the frequency of smokers in the Czech Republic (18.2%)21, more smokers were 
found in the assessed group of patients (22.5%); however, the difference was not found to be statistically signifi-
cant. No statistically significant difference was found by the comparison of the mean age of the assessed group 
(41.3 years) and the general population in the region (42.2 years)22 using a one-sample t-test. Unfortunately, data 
on the distribution of manual/office jobs neither in the region nor in the Czech Republic are not available; hence, 
there is no way of knowing whether the occupational pattern differs in any way from the general population. The 
reference group (Table S2) of patients was selected based on the absence of chronic hypertrophic rhinitis and 
staying in the Moravian-Silesian region.
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Multivariate analysis. Multiple correspondence analysis revealed that the first factor plain retains 43.5% of 
the total inertia (variation). Biplot of the first factor plain is presented in Fig. 2. From the variables used for the 
construction of the model, presence statuses of CO  (cos2 = 0.524), C  (cos2 = 0.288), and SiO  (cos2 = 0.284) are 
well represented by the first axis, AlO  (cos2 = 0.497) an Ir  (cos2 = 0.35) by the second axis and Ti by both the first 
two axes—although to a lesser extent  (cos2 = 0.227,  cos2 = 0.318, respectively). The supplementary variables align 
mostly alongside the first axis, while the most prominent variable is the diagnosis—the only supplementary vari-
able significantly represented by the first axis  (cos2 = 0.336). Other supplementary variables were not correlated 
with any of the axes—with the notable exception of smoking status and the second axis.
The results show that there is indeed a difference between the phases found in mucosa tissues from patients 
with chronic rhinitis and controls. Moreover, this difference is mainly in terms of the confirmed presence of some 
of the surveyed compounds (CO, C, SiO and Ti) in tissues of chronic hypertrophic rhinitis diagnosed patients. 
The correlation of the smoking status with the second axis suggests an interesting possible relationship between 
smoking and presence of AlO, Ir and Ti, although tangential to the diagnosis.
Bivariate analysis. A significant association was found for sex and both, occupation and smoking status. In the 
surveyed group of individuals, the occupation of males was skewed to manual and outdoor labour (p = 0.01); 
they were also more likely to be smokers (p = 0.02), as revealed by the chi-squared goodness-of-fit test. Smokers 
in the dataset had CO determined in their mucosa more often (p = 0.04); however, this observation is inseparable 
from the link between manual/outdoor labour and CO presence (p = 0.01 and < 0.01, respectively)—manual and 
outdoor workers tended to smoke more (and were, mostly, male). While smokers were clearly overrepresented 
in the outdoor working patients, the CO presence was overrepresented in smoking individuals among both 
the outdoor and indoor workers, urban aerosol itself contains a substantial amount of carbonaceous material 
(20–80%)23.
With regards to the diagnostic criterion, a significant association was observed for C, Ti and CO as revealed 
by the chi-squared goodness-of-fit test (p < 0.01, p = 0.01 and p = 0.01, respectively). Rhinitis-diagnosed indi-
viduals had the presence of all these compounds determined in their mucosa more often than controls (Fig. 3).
Interesting relationship was found between the age of the individuals in the rhinitis-diagnosed and control 
groups. Controls had a higher mean age (t-test, p < 0.01) than those diagnosed with chronic rhinitis (Fig. 4). In 
light of the aforementioned association of the presence of certain compounds in the mucosa and chronic rhinitis 
diagnosis, this means that controls had a lower presence of these compounds in their tissue despite the longer 
time they had to accumulate them. This was especially relevant for the case of the individuals with C detected 
in their mucosa who had significantly lower age than those with no presence of C (t-test, p = 0.01). Since there 
was no association with age and occupational factors, this implies that the tendency to develop chronic rhinitis 
connected to the accumulation of certain compounds in nasal mucosa may be at least partially innate or due 
to yet unknown environmental factor. Everyday life exposure should, however, be also considered. On the one 
hand, the higher age of the control group rules out the presence of particles in nasal mucosa as merely a result of 
Figure 1.  Selected spectra of the compounds found in the hypertrophic tissue samples, measured by 
Raman microspectroscopy.  (TiO2-A—anatase,  TiO2-R—rutile, AC—amorphous carbon,  CaCO3—calcite, 
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a life-long exposure, on the other hand, it should not be unduly emphasised. Since obtaining the control tissue 
samples from healthy subjects of comparable age would be unethical, the control tissues came from individuals 
who died from unknown causes and were, thus, inherently of a higher mean age. At the same time no inflamma-
tion or hypertrophy was found in the control inferior turbinate (see Table S2), hence, the comparison strengthens 
the association between the hypertrophic rhinitis and the observed particles.
The presence of carbon may be related to the ambient air pollution—especially with outdoor/indoor airborne 
particulate matter containing trace metals, antigens and carbon—mainly in the form of glassy carbon, carbon 
black or soot. Exposure to particulate matter has been correlated to the living location—namely its vicinity to 
busy roads and highways leading to elevation of the heavy metal levels in the indoor  dust4. Amorphous carbon 
is also present in most printer inks, so the presence of AC (consisting mainly of carbon black) in the mucosa 
tissue may be related to the release of submicron particles during the printing processes that are commonplace 
Figure 2.  MCA biplot.
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in  offices24. Road traffic and associated vehicle non-exhausts emissions are also a significant source of many ele-
ments released into the environment, e.g. Fe, Cu, S, Zn, Sn, Si, Mg, Al, Ba, and  C25.
Health risks. It is not possible to decidedly establish whether were the determined compounds present in 
the tissues prior to the development of the chronic hypertrophic rhinitis and, thus, led to the chronic inflam-
mation of the mucosa tissue or they entered the tissue when the disease was developed. Microparticles are, by 
their nature, rather invasive and reactive, hence, they could interfere with extracellular matrix and participate 
on polyposis formation. However, this process has not been studied so far and is interesting idea for further 
research in this field.
Nevertheless, many of the detected compounds are likely to be of exogenous origin and with a known negative 
impact on living organisms. For example, the graphite in the micro- and nano-scale can induce cytotoxicity of 
LDH (lactate dehydrogenase) and cause a pro-inflammatory reaction of TNF—α (tumour necrosis factor α) on 
RAW 264.7  macrophages26. According to Linberg et al., graphite nanofibers are genotoxic in human bronchial 
epithelial BEAS 2B cells in vitro27. Found iron oxides  (Fe2O3,  Fe3O4) also play an important negative role concern-
ing the human body. Ferrous oxide as fume or dust can cause pneumoconiosis (Siderosis) in the human  lung28.
There is no known physiological process through which the titania is formed naturally in the human body—
and yet the  TiO2 was present in more than half of the examined samples. All the detected titania is, hence, 
of exogenic and environmental origin. In the form of nanoparticles,  TiO2 has several unique characteristics 
making it a common ingredient in the pharmaceutical and cosmetic industry; hence it is becoming ubiquitous 
in the human  environment29,30. Due to the large relative surface area and high oxidation–reduction potential, 
nano-TiO2 is highly reactive, which may negatively impact both environment and human health. Namely, in its 
micro- to nanostructured form, it is known to interfere with the human body  negatively31–34. Titanium dioxide 
nanoparticles may lead to inflammation, fibrosis and lung tumours in humans and are, hence, classified accord-
ing to International Agency for Research on Cancer (IARC) as potential  carcinogens29,35,36. They can also have a 
genotoxic effect leading to (among others) apoptosis or chromosomal  instability37. Although  TiO2 is present in 
many daily necessities (cosmetics, pharmaceuticals, packaging, food) and humans are exposed to it frequently, 
it was detected only in one case in the reference samples (Table S2).
The limitation of the study is that it cannot be entirely excluded that some microsized particles found in the 
nasal mucosa in the rhinitis-diagnosed group can come from “contaminated” nasal steroids spray used for the 
treatment of chronic hypertrophic rhinitis. However, such contamination, especially with the microparticles 
identified in this study, is not likely. To clarify this issue, it would be interesting to examine inferior turbinate 
mucosa from patients with chronic hypertrophic rhinitis who were not treated with nasal steroids. However, 
before surgery, conservative treatment with nasal steroids is always indicated, it would be, thus, unethical to 
schedule a patient for surgery without the preceding conservative treatment.
Moreover, the conservative treatment with nasal steroid sprays may be inefficient in some patients suffering 
from hypertrophic rhinitis because the steroid only inhibits the inflammatory response, but it does not affect its 
cause. If the mucosal turbinate hypertrophy is, indeed, caused by the presence of the particles in the tissue, the 
microparticle-induced continual irritation may counteract the anti-inflammatory effect of the medication. The 
presence of the particles in the hypertrophic inferior turbinate may also be an indicator of their presence deeper 
in the airways or elsewhere in the body of the patient and, hence, underlying microparticle-induced chronic 
Figure 4.  Boxplot of age of rhinitis-diagnosed and non-rhinitis individuals.
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health issues which do not have such easily recognised immediate symptoms as chronic rhinitis but may cause 
severe health deterioration and decreased well-being in the long term.
Although the association between the development of chronic rhinitis and the presence of particles was 
observed in the assessed tissue samples, the specific inflammation- and hypertrophy-inducing mechanism is 
yet to be established. In addition, the links between the presence of microparticles in the inferior turbinate and 
either their presence elsewhere in the body of the patient or other idiopathic ailments are also worth investigating 
and should be the aim of further studies.
Conclusion
The diagnosis status was the key factor explaining the variation in the data when assessed by Multiple correspond-
ence analysis; specific relationships with chronic hypertrophic rhinitis were observed in the cases of amorphous 
carbon, titanium dioxide and carbonate compounds. All of these compounds were present significantly more 
in the mucosa of diagnosed patients. Carbonates also seem to be related to smoking and outdoor occupation 
(which were also interrelated). In contrast to the rhinitis-diagnosed patients, only titanium dioxide and amor-
phous carbon were found in controls. Interestingly, control group had a significantly higher mean age than the 
group of rhinitis-diagnosed patients meaning that longer time to accumulate the observed compounds is not a 
predictor of their presence, while the diagnosis is. Thus, it can be concluded that the presence of these compounds 
may be linked to upper respiratory system diseases, specifically to chronic hypertrophic rhinitis and, possibly, 
chronic rhinosinusitis. Whether this link is causal or whether another, underlying cause exists for both of these 
phenomena has to be investigated in a further study.
Thus, the study shows that many compounds were detected in the mucosa of the patients with chronic rhinitis, 
namely titanium dioxide, amorphous carbon, calcite, ankerite, magnetite, magnesite, graphite, hematite, barite, 
and siderite. Since many of these detected micron and submicron particles were shown to have a harmful effect 
on the human body, the identification and characterisation of such chemicals compounds in a living organism 
could contribute to the overall picture of the health of the individual and lead to a better understanding of the 
possible causes not only in the chronic rhinitis with unclear aetiology, also in other idiopathic diseases.
Data availability
The data presented in this study are available in article and supplementary materials.
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